April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Analysis of SLC4A11 and COL8A2 Mutations in Fuchs Endothelial Corneal Dystrophy (FECD)
Author Affiliations & Notes
  • M. A. Minear
    Duke Center for Human Genetics, Durham, North Carolina
  • N. A. Afshari
    Ophthalmology, Duke University Eye Center, Durham, North Carolina
  • E. Balajonda
    Ophthalmology, Duke University Eye Center, Durham, North Carolina
  • B. Zhao
    Duke Center for Human Genetics, Durham, North Carolina
  • J. Rimmler
    Duke Center for Human Genetics, Durham, North Carolina
  • Y.-J. Li
    Duke Center for Human Genetics, Durham, North Carolina
  • G. K. Klintworth
    Ophthalmology, Duke University Eye Center, Durham, North Carolina
  • S. G. Gregory
    Duke Center for Human Genetics, Durham, North Carolina
  • Footnotes
    Commercial Relationships  M.A. Minear, None; N.A. Afshari, None; E. Balajonda, None; B. Zhao, None; J. Rimmler, None; Y.-J. Li, None; G.K. Klintworth, None; S.G. Gregory, None.
  • Footnotes
    Support  NIH Grant 5R01EY016514, Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4639. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. A. Minear, N. A. Afshari, E. Balajonda, B. Zhao, J. Rimmler, Y.-J. Li, G. K. Klintworth, S. G. Gregory; Analysis of SLC4A11 and COL8A2 Mutations in Fuchs Endothelial Corneal Dystrophy (FECD). Invest. Ophthalmol. Vis. Sci. 2010;51(13):4639.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine whether previously reported mutations in COL8A2 and SLC4A11, two genes implicated in Fuchs endothelial corneal dystrophy (FECD), could be identified in a small sample of our dataset of FECD cases. We also sought to detect novel mutations in these genes that may influence FECD pathogenesis.

Methods: : FECD patients were recruited through an ongoing study at the Duke University Eye Center. Fourteen individuals diagnosed with FECD before 50 years of age (early onset cases) were used for COL8A2 sequencing, and 24 individuals diagnosed after 50 years of age (late onset cases) with tissue-confirmed diagnoses were selected for SLC4A11 sequencing. All sequences were generated on a 3730XL DNA Analyzer (Applied Biosystems Inc.) and were analyzed using the program Sequencher. Unrelated control individuals (over 60 years of age) were used to verify the presence of variations detected in cases.

Results: : The p.L450W mutation in COL8A2, which has been implicated in early onset FECD, was not detected in any of our 14 early onset cases. Other reported COL8A2 mutations, including p.R155Q, p.R304Q, p.R434H, p.Q455K, p.Q455V, and p.T502M were also not detected in these 14 cases. In addition, the p.E399K, p.G709E, p.T754M, and c.99-100delTC mutations in SLC4A11 were not present in the 24 late onset cases. We identified several known synonymous polymorphisms in our cases, including rs35841184 in COL8A2 and rs34460295, rs3827075, rs38033956, rs6084312, rs62208067, and rs4128160 in SLC4A11.

Conclusions: : We did not detect any of the previously reported FECD mutations in COL8A2 or SLC4A11 within a representative sample of our Caucasian FECD subjects. While our sample size limits our ability to draw conclusions about the role these mutations and genes play in FECD pathogenesis, our results suggest that other genetic factors may influence the development of FECD.

Keywords: cornea: endothelium • gene screening • candidate gene analysis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×